Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Benjamin J. Hindson currently holds 424,779 shares of 10x Genomics, Inc. (TXG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benjamin J. Hindson has been a net seller of TXG stock. They have purchased $0 and sold $124.6M worth of shares.
Benjamin J. Hindson's most recent insider trade was on Feb 23, 2026, when they sold 7,826 shares at $18.58 per share.
Benjamin J. Hindson serves as Executive at 10x Genomics, Inc. (TXG). They have executed 211 insider transactions totaling $124.6M over their tenure at the company.
Benjamin J. Hindson holds the position of Executive at 10x Genomics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Benjamin J. Hindson has shown a selling trading pattern, with $0 in total purchases and $124.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Benjamin J. Hindson was on Jan 3, 2022, when they sold $3.0M worth of TXG shares. This transaction involved 39,582 shares at $74.58 per share.
Benjamin J. Hindson currently owns 424,779 shares of 10x Genomics, Inc. (TXG), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Benjamin J. Hindson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Benjamin J. Hindson has 211 Form 4 filings on record as an insider at 10x Genomics, Inc..
Set alerts for Benjamin J. Hindson and 40,000+ other insiders.